PACS
PACS GroupAAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
Primary-source evidence is strong and the May 11, 2026 earnings release was clearly constructive, but the current setup still looks like a monitoring-style long rather than a full rerate. News flow is concentrated around the Q1 print, social coverage is not provided, and the packet does not include post-print analyst revision data, so improving fundamentals are only partly validated by external follow-through.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
PACS reported Q1 2026 revenue of $1.42 billion, net income of $80.7 million, and adjusted EBITDA of $170.4 million, then raised full-year adjusted EBITDA guidance to $605 million-$625 million, reaffirmed revenue guidance of $5.65 billion-$5.75 billion, and disclosed a $250 million share repurchase authorization effective May 7, 2026. [#SEC-8K-2026-05-11]
Q1 adjusted EBITDA included about $16.3 million of net benefit from California WQIP payments that were not in prior guidance because amount and timing were uncertain, so some of the quarter's margin upside is not a clean recurring run-rate. [#SEC-8K-2026-05-11]
Same-store SNF revenue rose 8.0%, occupancy improved to 90.9%, overall skilled mix reached 30.5%, 78.4% of the skilled nursing portfolio held 4- or 5-star CMS Quality Measure ratings, operating cash flow was $236.3 million, and available liquidity was $795.1 million, supporting continued operating execution and capital deployment. [#SEC-8K-2026-05-11]
Recommendation
No formal recommendation provided.

